Cost-Effectiveness of Rituximab in the Treatment of Diffuse Large B-Cell Non-Hodgkin's Lyphoma Patients (Dlbcl) in China
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.08.271
https://www.valueinhealthjournal.com/article/S1098-3015(16)30851-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2732
First Page :
A888
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30851-8&doi=10.1016/j.jval.2016.08.271